Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection

Journal of Viral Hepatitis

Volumn 13, Issue 1, 2006, Pages 5-10

  Ansaldi, F ^a   Bruzzone, B ^a   Testino, G ^b   Bassetti, M ^b   Gasparini, R ^a   Crovari, P ^a   Icardi, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Antigen; Diagnosis; HCV; Immunoassay; Window period

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; EARLY DIAGNOSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIREMIA; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; GROWTH, DEVELOPMENT AND AGING; HEPATITIS C VIRUS; METHODOLOGY; REPRODUCIBILITY; VIROLOGY;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 33644874357     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00646.x     Document Type: Article

References (23)

1. Barrera JM Francis B Ercilla G et al Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA Vox Sang 1995 68 15 18
2. Busch MP Kleinman SH Committee report: nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases Transfusion 2000 40 143 159
3. Food and Drug Administration Guidance for industry: use of nucleic acid tests on pooled and individual samples from blood donors and appropriately reduce the risk of transmission of HIV-1 and HCV Federal Register 2002 67 17077
4. Velati C Baruffi L Romanò L Fomiatti L Carreri V Zanetti A Introduction of NAT method of screening blood donors in Italy: reports of the two years' of experience and a re-evaluation of residual risk Blood Transfus 2003 4 368 378
5. Anonimous Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology Vox Sang 2002 82 87 111
6. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products Note for Guidance on Plasmaderivated Medicinal Products CPMP/BWP/269/95 rev.3 London, UK 1 32 25 January 2001 q2
7. Simmonds P Kurtz J Tedder R The UK blood transfusion service: over a (patent) barrel Lancet 2002 359 1713 1714
8. Courouce AM Le Marrec N Bouchardeau F et al Efficacy of HCV core antigen detection during the preseroconversion period Transfusion 2000 40 1198 1202
9. Icardi G Ansaldi F Bruzzone BM et al Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen J Clin Microbiol 2001 39 3110 3114
10. Nubling CM Unger G Chudy M Raia S Lower J Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase Transfusion 2002 42 1037 1045
11. Muerhoff AS Jiang L Shad D Detection of hepatitis C virus core antigen in human serum and plasma using an automated chemiluminescent immunoassay Transfusion 2002 42 349 356
12. Pawlotsky JM Use and interpretation of virological tests for hepatitis C Hepatology 2002 36 65 73
13. CDC Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus MMWR Morb Mortal Wkly Rep 2003 52 1 15
14. Stramer SL Glynn SA Kleinman SH et al Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing N Engl J Med 2004 351 760 768
15. Grant PR Sims CM Tedder RS Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion Transfusion 2002 42 1032 1036
16. Eiras A Sauleda S Planelles D et al HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years Transfusion 2003 43 713 719
17. Dow BC Munro H Buchanan I et al Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening Vox Sang 2004 86 15 20
18. Khan N Aswad S Shidban H et al Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center J Clin Virol 2004 30 175 182
19. Letowska M Brojer E Mikulska M Gronowska A Rosiek A. Hepatitis C core antigen in Polish blood donors Transfusion 2004 44 1067 1071
20. Laperche S Le Marrec N Simon N et al A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection Transfusion 2003 43 958 962
21. Maynard M Pradat P Berthillon P et al Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy J Viral Hepat 2003 10 318 323
22. Decker RH Diagnosis In Zuckermann AJ Thomas HC eds Viral Hepatitis. Scientific Basis and Clinical Management New York Churchill Livingstone 1993 165 184
23. World Health Organization (WHO) Operational characteristics of commercially available assays to determine antibodies to HIV-1 and HIV-2 in human sera Report 3, Global Programme on AIDS/RES/91.1 Geneva, Switzerland WHO 1991